139 related articles for article (PubMed ID: 38447738)
21. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.
Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS
Gastroenterology; 2013 Aug; 145(2):312-9.e1. PubMed ID: 23673354
[TBL] [Abstract][Full Text] [Related]
22. Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression.
Klaver E; Bureo Gonzalez A; Mostafavi N; Mallant-Hent R; Duits LC; Baak B; Böhmer CJM; van Oijen AHAM; Naber T; Scholten P; Meijer SL; Bergman JJGHM; Pouw RE;
United European Gastroenterol J; 2021 Oct; 9(8):929-937. PubMed ID: 34228885
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
[TBL] [Abstract][Full Text] [Related]
24. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
[TBL] [Abstract][Full Text] [Related]
25. Clinical and pathological predictors of failure of endoscopic therapy for Barrett's related high-grade dysplasia and early esophageal adenocarcinoma.
Shimamura Y; Iwaya Y; Kobayashi R; Rodriguez de Santiago E; Muwanwella N; Raftopoulos S; Mosko JD; May GR; Kandel G; Kortan P; Marcon N; Teshima CW
Surg Endosc; 2021 Oct; 35(10):5468-5479. PubMed ID: 32989547
[TBL] [Abstract][Full Text] [Related]
26. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.
Codipilly DC; Chandar AK; Singh S; Wani S; Shaheen NJ; Inadomi JM; Chak A; Iyer PG
Gastroenterology; 2018 Jun; 154(8):2068-2086.e5. PubMed ID: 29458154
[TBL] [Abstract][Full Text] [Related]
28. Clinical Relevance of Random Biopsies From the Esophagogastric Junction After Complete Eradication of Barrett's Esophagus is Low.
Frederiks CN; van Munster SN; Nieuwenhuis EA; Alvarez Herrero L; Alkhalaf A; Schenk BE; Schoon EJ; Curvers WL; Koch AD; de Jonge PF; Tang T; Nagengast WB; Westerhof J; Houben MHMG; Bergman JJGHM; Pouw RE; Weusten BLAM;
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2260-2269.e9. PubMed ID: 36423874
[TBL] [Abstract][Full Text] [Related]
29. Long-term durability of radiofrequency ablation for Barrett's-related neoplasia.
Haidry R; Lovat L
Curr Opin Gastroenterol; 2015 Jul; 31(4):316-20. PubMed ID: 26039723
[TBL] [Abstract][Full Text] [Related]
30. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer).
Ell C; May A; Pech O; Gossner L; Guenter E; Behrens A; Nachbar L; Huijsmans J; Vieth M; Stolte M
Gastrointest Endosc; 2007 Jan; 65(1):3-10. PubMed ID: 17185072
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients.
Ferguson MK; Durkin A
J Gastrointest Surg; 2002; 6(1):29-35; discussion 36. PubMed ID: 11986015
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics of young patients with early Barrett's neoplasia.
Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
[TBL] [Abstract][Full Text] [Related]
33. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
34. Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.
Coleman HG; Bhat SK; Murray LJ; McManus DT; O'Neill OM; Gavin AT; Johnston BT
Am J Gastroenterol; 2014 Apr; 109(4):527-34. PubMed ID: 24589668
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett's Esophagus.
Reddy CA; Tavakkoli A; Chen VL; Korsnes S; Bedi AO; Carrott PW; Chang AC; Lagisetty KH; Kwon RS; Elmunzer BJ; Orringer MB; Piraka C; Prabhu A; Reddy RM; Wamsteker E; Rubenstein JH
Dig Dis Sci; 2021 May; 66(5):1580-1587. PubMed ID: 32519141
[TBL] [Abstract][Full Text] [Related]
36. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic eradication therapy for Barrett's oesophagus: state of the art.
Kolb JM; Wani S
Curr Opin Gastroenterol; 2020 Jul; 36(4):351-358. PubMed ID: 32487852
[TBL] [Abstract][Full Text] [Related]
38. Patients With Barrett's Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer.
Kestens C; Offerhaus GJ; van Baal JW; Siersema PD
Clin Gastroenterol Hepatol; 2016 Jul; 14(7):956-962.e1. PubMed ID: 26748222
[TBL] [Abstract][Full Text] [Related]
39. Incidence of Progression of Persistent Nondysplastic Barrett's Esophagus to Malignancy.
Peters Y; Honing J; Kievit W; Kestens C; Pestman W; Nagtegaal ID; van der Post RS; Siersema PD
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):869-877.e5. PubMed ID: 30213587
[TBL] [Abstract][Full Text] [Related]
40. Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.
Kamboj AK; Goyal R; Vantanasiri K; Sachdeva K; Passe M; Lansing R; Garg N; Chandi PS; Ramirez FC; Kahn A; Fukami N; Wolfsen HC; Krishna M; Pai RK; Hagen C; Lee HE; Wang KK; Leggett CL; Iyer PG
Am J Gastroenterol; 2024 Apr; 119(4):662-670. PubMed ID: 37795907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
